Great Lakes Advisors LLC Acquires New Shares in Henry Schein, Inc. $HSIC

Great Lakes Advisors LLC acquired a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the 1st quarter, Holdings Channel.com reports. The fund acquired 65,363 shares of the company’s stock, valued at approximately $4,477,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. UMB Bank n.a. boosted its position in Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock worth $73,000 after purchasing an additional 201 shares during the last quarter. HB Wealth Management LLC boosted its position in Henry Schein by 1.5% in the first quarter. HB Wealth Management LLC now owns 15,419 shares of the company’s stock worth $1,056,000 after purchasing an additional 226 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Henry Schein by 1.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company’s stock worth $1,155,000 after purchasing an additional 229 shares during the last quarter. Allworth Financial LP boosted its position in Henry Schein by 24.5% in the first quarter. Allworth Financial LP now owns 1,178 shares of the company’s stock worth $78,000 after purchasing an additional 232 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky boosted its position in Henry Schein by 2.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 9,619 shares of the company’s stock worth $659,000 after purchasing an additional 238 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Down 0.1%

NASDAQ HSIC opened at $67.65 on Wednesday. The stock’s 50 day moving average is $69.68 and its 200 day moving average is $69.60. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The stock has a market cap of $8.20 billion, a PE ratio of 21.82, a P/E/G ratio of 2.23 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business had revenue of $3.24 billion during the quarter, compared to analysts’ expectations of $3.22 billion. During the same period in the prior year, the firm posted $1.23 earnings per share. The firm’s revenue for the quarter was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HSIC. Evercore ISI raised Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 target price on the stock in a research report on Tuesday, August 26th. Wall Street Zen cut Henry Schein from a “buy” rating to a “hold” rating in a research report on Sunday. Robert W. Baird reissued a “neutral” rating and issued a $72.00 target price (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. UBS Group lowered their price objective on Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 6th. Finally, Baird R W cut Henry Schein from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 14th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.